FIZRX | VMVAX | FIZRX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 2 years | 13 years | - |
Gain YTD | 13.615 | 14.946 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 512M | 30.5B | 2% |
Annual Yield % from dividends | 0.78 | 2.14 | 37% |
Returns for 1 year | 25.48 | 25.35 | 101% |
Returns for 3 years | N/A | 20.71 | - |
Returns for 5 years | N/A | 48.82 | - |
Returns for 10 years | N/A | 100.88 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
QRVLX | 33.05 | N/A | N/A |
FPA Queens Road Value | |||
BMSYX | 15.51 | -0.03 | -0.19% |
MFS Blended Research Mid Cap Eq R6 | |||
SFEPX | 23.93 | -0.06 | -0.25% |
Guggenheim StylePlus - Large Core P | |||
USLCX | 53.50 | -0.25 | -0.47% |
JHancock U.S. Global Leaders Growth C | |||
RGLAX | 23.96 | -0.14 | -0.58% |
American Funds Global Insight R-1 |